B
BostonGene
Health Tech & Medtech · Waltham, United States · Founded 2015 Unicorn
Investors
3 investors on BostonGene's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where BostonGene has talent and traffic
(7 of 368 staff)
team presence
across markets
Patent intelligence
$88M patent portfolio · 52 active families
Where BostonGene concentrates vs peers
Each axis is a top-10 topic across BostonGene and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about BostonGene
An AI-synthesized read of the highest-engagement posts about BostonGene on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BostonGene on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.